767
Views
110
CrossRef citations to date
0
Altmetric
Review

Memory loss in Alzheimer’s disease: implications for development of therapeutics

&
Pages 1879-1891 | Published online: 09 Jan 2014

References

  • Nussbaum RL, Ellis CE. Alzheimer’s disease and Parkinson’s disease. N. Engl. J. Med.348(14), 1356–1364 (2003).
  • Alzheimer’s Association. Alzheimer’s disease facts and figures 2007. (2007).
  • Ferri C, Prince M, Brayne C et al. Global prevalence of dementia: a Delphi consensus study. Lancet366, 2112–2117 (2005).
  • Fillit H, Hill J. Economics of dementia and pharmacoeconomics of dementia therapy. Am. J. Geriatr. Pharmacother.3(1), 39–49 (2005).
  • Allegri RF, Butman J, Arizaga RL et al. Economic impact of dementia in developing countries: an evaluation of costs of Alzheimer-type dementia in Argentina. Int. Psychogeriatr.19(4), 705–718 (2007).
  • Lopez-Bastida J, Serrano-Aguilar P, Perestelo-Perez L, Oliva-Moreno J. Social–economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain. Neurology67, 2186–2191 (2006).
  • Andel R, Hyer K, Slack A. Risk factors for nursing home placement in older adults with and without dementia. J. Aging Health19, 213–228 (2007).
  • Clipp E. US Department of Veterans Affairs HSR&D Study NRI 95-218, Informal Caregivers of Veterans with Dementia: Cost, QOL, and Service Use. (2005).
  • Leon J, Neumann PJ, Hermann RC et al. Health-related quality-of-life and service utilization in Alzheimer’s disease: a cross-sectional study. Am. J. Alzheimers Dis. Other Demen.15(2), 94–108 (2000).
  • Clyburn LD, Stones MJ, Hadjistavropoulos T, Tuokko H. Predicting caregiver burden and depression in Alzheimer’s disease. J. Gerontol.55(1), S2–S13 (2000).
  • Stahl SM. The new cholinesterase inhibitors for Alzheimer’s disease, part 2: illustrating their mechanisms of action. J. Clin. Psychiatry61(11), 813–814 (2000).
  • Seeman P, Caruso C, Lasaga M. Memantine agonist action at dopamine D2High receptors. Synapse62(2), 149–153 (2008).
  • Raina P, Santaguida P, Ismaila A et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann. Intern. Med.148(5), 379–397 (2008).
  • Van Marum RJ. Current and future therapy in Alzheimer’s disease. Fundamen. Clin. Pharmacol.22(3), 265–274 (2008).
  • Masters CL, Beyreuther K. Alzheimer’s centennial legacy: prospects for rational therapeutic intervention targeting the Aβ amyloid pathway. Brain129(11), 1763–1769 (2006).
  • Aisen PS, Gauthier S, Vellas B et al. Alzhemed: a potential treatment for Alzheimer’s disease. Curr. Alzheimer Res.4(4), 473–478 (2007).
  • Wilcock G, Black S, Hendrix S, Zavitz K, Swabb E, Laughlin M. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer’s disease: a randomised Phase II trial. Lancet Neurol.7(6), 483–493 (2008).
  • Lichtlen P, Mohajeri MH. Antibody-based approaches in Alzheimer’s research: safety, pharmacokinetics, metabolism and analytical tools. J. Neurochem.104(4), 859–874 (2008).
  • Squire LR. Memory systems of the brain: a brief history and current perspective. Neurobiol. Learn. Mem.82, 171–177 (2004).
  • Budson AE, Price BH. Memory dysfunction. N. Engl. J. Med.352, 692–699 (2005).
  • Tippett L, Meier S, Blackwood K, Diaz-Asper C. Category specific deficits in Alzheimer’s disease: fact or artefact? Cortex43(7), 907–920 (2007).
  • Davies RR, Graham KS, Xuereb JH, Williams GB, Hodges JR. The human perirhinal cortex and semantic memory. Eur. J. Neurosci.20(9), 2441–2446 (2004).
  • Starr JM, Loeffler B, Abousleiman Y et al. Episodic and semantic memory tasks activate different brain regions in Alzheimer disease. Neurology65, 266–269 (2005).
  • Hamann S, Monarch ES, Goldstein FC. Impaired fear conditioning in Alzheimer’s disease. Neuropsychologia40(8), 1187–1195 (2002).
  • Woodruff-Pak DS. Eyeblink classical conditioning differentiates normal aging from Alzheimer’s disease. Integr. Physiol. Behav. Sci.36, 87–108 (2001).
  • Libon DJ, Bogdanoff B, Cloud BS et al. Declarative and procedural learning, quantitative measures of the hippocampus, and subcortical white alterations in Alzheimer’s disease and ischaemic vascular dementia. J. Clin. Exp. Neuropsychol.20(1), 30–41 (1998).
  • Poe MK, Seifort LS. Implicit and explicit tests: evidence for dissociable motor skills in probable Alzheimer’s dementia. Percept. Mot. Skills85(2), 631–634 (1997).
  • Belleville S, Chertkow H, Gauthier S. Working memory and control of attention in persons with Alzheimer’s disease and mild cognitive impairment. Neuropsychology21(4), 458–469 (2007).
  • Kalpouzos G, Eustache F, de la Sayette V, Viader F, Chetalat G, Desgranges B. Working memory and FDG-PET dissociate early and late onset Alzheimer disease patients. J. Neurol.252(5), 548–558 (2005).
  • Yetkin FZ, Rosenberg RN, Weiner MF, Purdy PD, Cullum CM. fMRI of working memory in patients with mild cognitive impairment and probable Alzheimer’s disease. Eur. Radio.16(1), 193–206 (2006).
  • Fleischman DA, Wilson RS, Gabrieli JDE, Schneider JA, Bienias JL, Bennett DA. Implicit memory and Alzheimer’s disease neuropathology. Brain128, 2006–2015 (2005).
  • Golby A, Silverberg G, Race E et al. Memory encoding in Alzheimer’s disease: an fMRI study of explicit and implicit memory. Brain128(4), 773–787 (2005).
  • Lustig C, Buckner R. Preserved neural correlates of priming in old age and dementia. Neuron42(5), 865–875 (2004).
  • Wig GS, Grafton ST, Demos KE, Kelley WM. Reductions in neural activity underlie behavioral components of repetition priming. Nat. Neurosci.8, 1228–1233 (2005).
  • Nakamura H, Nakanishi M, Hamanaka T, Nakaaki S, Yoshida S. Semantic priming in patients with Alzheimer and semantic dementia. Cortex36(2), 151–162 (2000).
  • Hernandez M, Costa A, Juncadella M, Sebastian-Galles N, Rene R. Category-specific semantic deficits in Alzheimer’s disease: a semantic priming study. Neuropsychologia46(4), 935–946 (2008).
  • Chertkow H, Bub D, Bergman H, Bruemmer A, Merling A, Rothfleisch J. Increased semantic priming in patients with dementia of the Alzheimer’s type. J. Clin. Exp. Neuropsychol.16(4), 608–622 (1994).
  • Hodges JR. Memory in the dementias. In: The Oxford Handbook of Memory. Tulving E, Craik FIM (Eds). Oxford University Press, NY, USA (2000).
  • Geldmacher DS, Whitehouse PJ. Differential diagnosis of Alzheimer’s disease. Neurology48, 2S–9S (1997).
  • McKhann G, Drachman D, Folstein M, Katzman R, Price D. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology34, 939–944 (1984).
  • Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br. J. Psychiatry114, 797–811 (1968).
  • Mesulam MM. Principles of Behavioral and Cognitive Neurology (2nd Edition). Oxford University Press, NY, USA (2000).
  • Borson S, Scanlan JM, Watanabe J, Tu SP, Lessig M. Simplifying detection of cognitive impairment: comparison of the Mini-Cog and the Mini-Mental State Examination in a multiethnic sample. J. Am. Geriatr. Soc.53(5), 871–874 (2005).
  • Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res.12, 189–198 (1975).
  • Solomon PR, Hirschoff A, Kelly B et al. A 7 minute neurocognitive screening battery highly sensitive to Alzheimer’s disease. Arch. Neurol55, 349–355 (1998).
  • Welsh KA, Butters N, Hughes JP et al. Detection and staging of dementia in Alzheimer’s disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer’s Disease. Arch. Neurol.49, 448–452 (1992).
  • Ribot T. Les Maladies de la Mémoire. Librairie Germer Baillière, Paris, France (1882).
  • Sagar HJ, Cohen NJ, Sullivan EV, Corkin S, Growdon, JH. Remote memory function in Alzheimer’s disease and Parkinson’s disease. Brain111, 185–206 (1988).
  • Scoville WB, Milner B. Loss of recent memory after bilateral hippocampus lesions. J. Neurol. Neurosurg. Psychiatry20, 11–21 (1957).
  • Squire LR, Clark RE, Bayley PJ. Medial temporal lobe function and memory. In: The Cognitive Neurosciences (3rd Edition). Gazzaniga M (Ed.). MIT Press, Cambridge, MA, USA (2004).
  • Stenset V, Grambaite R, Reinvang I et al. Diaschisis after thalamic stroke: a comparison of metabolic and structural changes in a patient with amnesic syndrome. Acta Neurologica Scandinavica187, 68–71 (2007).
  • Hamani C, McAndrews MP, Cohn M et al. Memory enhancement induced by hypothalamic/fornix deep brain stimulation. Ann. Neurol.63(1), 119–123 (2008).
  • Tanaka Y, Miyazawa Y, Akaoka F, Yamada T. Amnesia following damage to the mammillary bodies. Neurology48(1), 160–165 (1997).
  • Yoneoka Y, Takeda N, Inoue A et al. Acute Korsakoff syndrome following mammillothalamic tract infarction. Am. J. Neuroradiol.25(6), 964–968 (2004).
  • Epstein RA, Higgins JS. Differential parahippocampal and retrosplenial involvement in three types of visual scene recognition. Cereb. Cortex17(7), 1680–1693 (2007).
  • Pang KC, Nocera R, Secor AJ, Yoder RM. GABAergic septohippocampal neurons are not necessary for spatial memory. Hippocampus11(6), 814–827 (2001).
  • Malkova L, Mishkin M. One-trial memory for object–place associations after separate lesions of hippocampus and posterior parahippocampal region in the monkey. J. Neurosci.23(5), 1956–1965 (2003).
  • Barnes J, Godbolt AK, Frost C et al. Atrophy rates of the cingulate gyrus and hippocampus in AD and FTLD. Neurobiol. Aging28(1), 20–28 (2007).
  • Scher AI, Xu Y, Korf ES et al. Hippocampal shape analysis in Alzheimer’s disease: a population-based study. Neuroimage36(1), 8–18 (2007).
  • Wang L, Miller JP, Gado MH et al. Abnormalities of hippocampal surface structure in very mild dementia of the Alzheimer type. Neuroimage30(1), 52–60 (2006).
  • Ishunina TA, Swaab DF. Increased neuronal metabolic activity and estrogen receptors in the vertical limb of the diagonal band of Broca in Alzheimer’s disease: relation to sex and aging. Exp. Neurol.183(1), 159–172 (2003).
  • Petersen RC. Mild cognitive impairment as a diagnostic entity. J. Intern. Med.256, 183–194 (2004).
  • Copenhaver BR, Rabin LA, Saykin AJ et al. The fornix and mammillary bodies in older adults with Alzheimer’s disease, mild cognitive impairment, and cognitive complaints: a volumetric MRI study. Psychiatry Res.147(2), 93–103 (2006).
  • Wisniewski HM, Sadowski M, Jakubowska-Sadowska K, Tarnawski M, Wegiel J. Diffuse, lake-like amyloid-β deposits in the parvopyramidal layer of the presubiculum in Alzheimer disease. J. Neuropathol. Exp. Neurol.57(7), 674–683 (1998).
  • Nakazawa K, Quirk MC, Chitwood RA et al. Requirement for hippocampal CA3 NMDA repceptors in associative memory recall. Science297, 211–218 (2002).
  • Shastri L. Episodic memory and cortico–hippocampal interactions. Trends Cogn. Sci.6(4), 162–168 (2002).
  • Teylor TJ, Rudy JW. The hippocampal indexing theory and episodic memory: updating the index. Hippocampus17(12), 1158–1169 (2007).
  • Di Paola M, Macaluso E, Carlesimo GA et al. Episodic memory impairment in patients with Alzheimer’s disease is correlated with entorhinal cortex atrophy. J. Neurol.254(6), 774–781 (2007).
  • Ohm TG. The dentate gyrus in Alzheimer’s disease. Prog. Brain Res.163, 723–740 (2007).
  • Adachi M, Kawakatsu S, Hosoya T et al. Morphology of the inner structure of the hippocampal formation in Alzheimer disease. Am. J. Neuroradiol.24(8), 1575–1581 (2003).
  • McGaugh JL. Memory: a century of consolidation. Science287, 248–251 (2000).
  • Wiltgen B, Brown R, Talton L, Silva A. New circuits for old memories: the roles of the neocortex in consolidation. Neuron44(1), 101–108 (2004).
  • Axmacher N, Haupt S, Fernandez G, Elger CE, Fell J. The role of sleep in declarative memory consolidation – direct evidence by intracranial EEG. Cereb. Cortex18(3), 500–507 (2008).
  • Schabus M, Gruber G, Parapatics S et al. Sleep spindles and their significance for declarative memory consolidation. Sleep27(8), 1443–1445 (2004).
  • Petit D, Gagnon J, Fantini M, Ferini-Strambi L, Montplaisir J. Sleep and quantitative EEG in neurodegenerative disorders. J. Psychosom. Res.56(5), 487–496 (2004).
  • Yonelinas AP. The nature of recollection and familiarity: a review of 30 years of research. J. Mem. Lang.46, 441–517 (2002).
  • Smith JA, Knight RG. Memory processing in Alzheimer’s disease. Neuropsychologia46, 666–682 (2002).
  • Gallo DA, Sullivan AL, Daffner KR, Schacter DL, Budson AE. Associative recognition in Alzheimer’s disease: evidence for impaired recall-to-reject. Neuropsychology18, 556–563 (2004).
  • Budson AE, Daffner KR, Desikan R, Schacter DL. When false recognition is unopposed by true recognition: gist based memory distortion in Alzheimer’s disease. Neuropsychology14, 277–287 (2000).
  • Brown CM, Aggleton JP. Recognition memory: what are the roles of the perirhinal cortex and hippocampus? Nat. Rev. Neurosci.2, 51–61 (2001).
  • Eichenbaum H, Yonelinas AP, Ranganath C. The medial temporal lobe and recognition memory. Annu. Rev. Neurosci.30, 123–152 (2007).
  • Buckner RL, Schacter DL. Neural correlates of memory’s successes and sins. In: The Cognitive Neurosciences (3rd Edition). Gazzaniga M (Ed.). MIT Press, Cambridge, MA, USA (2004).
  • Budson AE, Sullivan AL, Mayer E, Daffner KR, Black PM, Schacter DL. Suppression of false recognition in Alzheimer’s disease and in patients with frontal lobe lesions. Brain125, 2750–2765 (2002).
  • Schnider A. Spontaneous confabulation, reality monitoring, and the limbic system. Brain Res. Rev.36, 150–160 (2001).
  • Budson AE, Simons JS, Sullivan AL et al. Memory and emotions for the September 11, 2001, terrorist attacks in patients with Alzheimer’s disease, patients with mild cognitive impairment, and healthy older adults. Neuropsychology18, 315–327 (2004).
  • Budson AE, Simons JS, Waring JD, Sullivan AL, Hussion T, Schacter DL. Memory for the September 11, 2001, terrorist attacks one year later in patients with Alzheimer’s disease, patients with mild cognitive impairment, and healthy older adults. Cortex43, 875–888 (2007).
  • Cooper JM, Shanks MF, Venneri A. Provoked confabulations in Alzheimer’s disease. Neuropsychologia44(10), 1697–1707 (2006).
  • Gilboa A, Alain C, Stuss DT, Melo B, Miller S, Moscovitch M. Mechanisms of spontaneous confabulations: a strategic retrieval account. Brain129(6), 1399–1414 (2006).
  • Lee E, Meguro K, Hashimoto R et al. Confabulations in episodic memory are associated with delusions in Alzheimer’s disease. J. Geriatr. Psychiatry Neurol.20(1), 34–40 (2007).
  • Lee E, Akanuma K, Meguro M, Ishii H, Yamaguchi S, Meguro K. Confabulations in remembering past and planning future are associated with psychiatric symptoms in Alzheimer’s disease. Arch. Clin. Neuropsychol.22(8), 949–956 (2007).
  • Geroldi C, Bresciani L, Zanetti O, Frisoni GB. Regional brain atrophy in patients with mild Alzheimer’s disease and delusions. Int. Psychogeriatr.14(4), 365–378 (2002).
  • Senanarong V, Cummings JL, Fairbanks L et al. Agitation in Alzheimer’s disease is a manifestation of frontal lobe dysfunction. Dement. Geriatr. Cogn. Disord.17(1), 14–20 (2004).
  • Check E. Nerve inflammation halts trial for Alzeimer’s drug. Nature415, 462 (2002).
  • Greenberg SM, Bacskai BJ, Hyman BT. Alzheimer disease’s double-edged vaccine. Nat. Med.9, 389–390 (2003).
  • Nicoll JAR, Wilkinson D, Holmes C, Steart P, Markham H, Weller RO. Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report. Nat. Med.9, 448–452 (2003).
  • Mohajeri MH. The underestimated potential of the immune system in prevention of Alzheimer’s disease pathology. Bioessays29(9), 927–932 (2007).
  • Mohs RC, Rosen WG, Davis KL. The Alzheimer’s disease assessment scale: an instrument for assessing treatment efficacy. Psychopharmacol. Bull.19(3), 448–450 (1983).
  • Lynch CA, Walsh C, Blanco A et al. The clinical dementia rating sum of box score in mild dementia. Dement. Geriatr. Cogn. Disord.21(1), 40–43 (2006).
  • Kinjo H. Improving sensitivity of the recognition task in the Alzheimer’s disease assessment scale. Psychol. Rep.100(2), 420–426 (2007).
  • Budson AE, Michalska KJ, Rentz DM et al. Use of a false recognition paradigm in an Alzheimer’s disease clinical trial: a pilot study. Am. J. Alzheimers Dis. Other Demen.17, 93–100 (2002).
  • Cummings JL. Alzheimer’s disease. N. Engl. J. Med.351, 56–67 (2004).
  • Holmes C, Wilkinson D, Dean C et al. The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer’s disease. Neurology63(2), 214–219 (2004).
  • Friedman D, Johnson R. Event-related potential studies of memory encoding and retrieval: a selective review. Microsc. Res. Tech.51, 6–28 (2000).
  • Ally BA, Simons JS, McKeever JD, Peers PV, Budson AE. Parietal contributions to recollection: electrophysiological evidence from aging and patients with parietal lesions. Neuropsychologia46, 1800–1812 (2008).
  • Johnson R, Kreiter K, Russo B, Zhu J. A spatio–temporal analysis of recognition-related event-related brain potentials. Int. J. Psychophysiol.29, 83–104 (1998).
  • Rugg MD, Schloerscheidt AM, Mark RE. An electrophysiological comparison of two indices of recollection. J. Mem. Lang.39, 47–69 (1998).
  • Wolk DA, Signoff ED, DeKosky ST. Recollection and familiarity in amnestic mild cognitive impairment: a global decline in recognition memory. Neuropsychologia46(7), 1965–1978 (2008).
  • Ashford J, Borson S, O’Hara B et al. Should older adults be screened for dementia? Alzheimers Dement.2(2), 76–85 (2006).
  • Ashford JW. Screening for memory disorder, dementia, and Alzheimer’s disease. Aging Health4(4), 399–432 (2008).
  • Ashford JW, Borson S, O’Hara R et al. Should older adults be screened for dementia? It is important to screen for evidence of dementia. Alzheimers Dement.3, 75–80 (2007).
  • Lipton RB, Katz MJ, Kuslansky G. Screening for dementia by telephone using the memory impairment screen. J. Am. Geriatr. Soc.51(10), 1382–1390 (2008).
  • Kaushik T, Schafer A, Webbe F, Freeman J, Erlanger D. Validation of the HeadMinder dementia screening battery (DSB): a 10-minute computerized screening for primary care. Arch. Clin. Neuropsychol.19, 972 (2004).
  • Becker SA, Webbe FM. Designing for older adult users of handheld technology. Conf. Proc. IEEE Eng. Med. Biol. Soc.3297–3300 (2006).
  • Berger TW, Glanzman DL. Toward Replacement Parts for the Brain: Implantable Biomimetic Electronics as Neural Prostheses. MIT Press, Cambridge, MA, USA (2005).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.